Status:
COMPLETED
Role of Dexamethasone in Transversus Abdominis Plane Block After Cesarean Section
Lead Sponsor:
Aswan University Hospital
Conditions:
Cesarean Section
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Our aim to study the efficacy of bupivacaine 0.25% with dexamethasone and that of bupivacaine 0.25% alone in transversus abdominis plane (TAP) block for postoperative analgesia in patients undergoing ...
Detailed Description
The pain and discomfort following cesarean delivery are mostly due to the abdominal wall incision and dissection of muscles; it delays early ambulation and breastfeeding. This can lead to postoperativ...
Eligibility Criteria
Inclusion
- healthy parturient (ASA I and II) scheduled to undergo LSCS under spinal anesthesia
Exclusion
- Participants had known sensitivity to bupivacaine
- patient refusal,
- localized infection over injection point
- patients with significant coagulopathies and
- with contraindications to regional anesthesia,
- patients with heart diseases, altered renal or liver functions,
- psychological disorders, patients with pregnancy-induced hypertension and
- gestational diabetes, chronic use of pain medications,
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03767920
Start Date
January 1 2019
End Date
August 1 2020
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University
Aswān, Egypt, 81528